Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_64f0c755a823771d8cb93f31b61f460a |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-6037 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-2207 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0005 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-385 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 |
filingDate |
1999-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41ef76d85fce573d37b85c315fd3c2c1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_093d228a79f79766880dec072f9b641c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4f029e9e1c31cc912ceeb2c25c3e38b1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aa06254e8b5024ab218e389172640f14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6a90992587cd069d917f50f7fb75a394 |
publicationDate |
2001-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-1076561-A2 |
titleOfInvention |
Combination therapy for the treatment of tumors |
abstract |
The present invention relates to a combination therapy method for treating gastrin-dependent tumors. The method comprises the immunization of a patient with an anti-gastrin (17) immunogenic composition in combination with the administration of chemotherapeutic agents such as 5-fluorouracil and leucovorin. |
priorityDate |
1998-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |